Does your brand need a check-up?
May 4, 2005Sales and Marketing
Brands are all about 'adding value'. To provide this value to our target customers we need to ensure we have …
Filling in the gaps in your team
May 4, 2005Business Services
Outsourcing as an integral element of a business strategy has waxed and waned in popularity and acceptability over the last …
Taking on the market leader
May 4, 2005Sales and Marketing
Launching a new product into a therapeutic area dominated by a 'gold standard' doctors' favourite is a tough task but …
Velcade moves up to second line treatment
April 28, 2005Sales and Marketing
Ortho Biotech's Velcade has received approval as a second-line treatment for patients with multiple myeloma in Europe, advancing it from …
EMEA advises against prescribing of antidepressants in children
April 28, 2005Sales and Marketing
Doctors across Europe will be discouraged from prescribing most modern antidepressants for children and adolescents following new EMEA advice.Investigations into …
Strattera sales fall back over continuing safety concerns
April 26, 2005Sales and Marketing
Lilly say it expects sales of Strattera to fall in 2005 because of continuing concerns over the safety of ADHD …
Woolley Pau wins Novo Nordisk insulin accounts
April 26, 2005Medical Communications
Following a four-way pitch, Convent Garden-based advertising agency Woolley Pau has been appointed by Novo Nordisk to work on its …
MHRA failing patients, warns report
April 26, 2005Sales and Marketing
MPs have called for an urgent review of the UK drugs regulator, saying that tougher regulation of the industry is …
Super surgeries become an election issue
April 26, 2005Labour plans to create 'super surgeries' designed to grant "entrepreneurial" GPs the opportunity to broaden their scope and offer patients …
Bextra withdrawal dents Pfizer’s sales juggernaut
April 22, 2005Sales and Marketing
The suspension and withdrawal of Pfizer's Cox-II inhibitor Bextra has forced the company to cut its profit forecast for 2005, …
PCT mergers won’t solve financial problems, warns report
April 19, 2005PCT mergers are unlikely to relieve the burden of financial pressures, according to a major report by the NHS Alliance.The …
US court rules in favour of Lilly’s Zyprexa
April 18, 2005Sales and Marketing
Lilly's US patent on blockbuster antipsychotic drug Zyprexa (olanzapine) has been upheld, after a Supreme Court ruled against its generic …
Labour makes clinical trials law a manifesto pledge
April 15, 2005Research and Development
The Labour party has promised to introduce new legislation which would oblige pharmaceutical companies to publish clinical trial data for …
Novartis signs respiratory deal with UK biotech companies
April 14, 2005Research and Development
Novartis has signed a deal with two UK biotech companies to develop and market a new treatment for chronic obstructive …
Ogilvy reshuffle sweetens Healthworld
April 14, 2005Medical Communications
The new Ogilvy Healthworld Advertising agency has been launched in the UK following a re-organisation at media communications giant WPP.The …
Eloxatin and Campto gain new NICE approval
April 13, 2005Sales and Marketing
NICE has recommended two more chemotherapy drugs for the first-line treatment of advanced colorectal cancer.The institute said that Sanofi-Aventis' Eloxatin …
Latest content
